Reinvent

In Reinvent, renowned CEO and business leader Fred Hassan explains how to transform a struggling business into a raging success by reinventing the culture, attitude, and behaviors of organizations and people. Leaders who want to change cultures and individuals need a cool head, a clear vision, and a well-refined ability to inspire that change. Here, Hassan explains how a productive organizational culture leads to real success.

The first part of the book focuses on how you, as a leader, can unleash your full powers by learning to be authentic, purposeful, and connected with your organization. The second part of the book focuses on groups, how to lead them, how to be a role model for the effort you expect, and how to keep winning and innovating. Taken together, these principles fuel smarter strategies, more effective execution, and better governance.

• Features practical, proven guidance appropriate for every business leader in any industry
• Ideal for corporate executives, managers, team leaders, human resources professionals, board members, and consultants
• Written by a renowned public speaker and former CEO known for turning around struggling companies

Revealing how you can make culture your secret weapon, Reinvent is the perfect tool for business leaders in highly competitive industries.

Fred Hassan is a Partner and Managing Director with the private equity firm, Warburg Pincus. He is also Chairman of Bausch + Lomb, as well as board member of Time Warner and Avon where he became non-executive chairman on January 1, 2013. Hassan is the former Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation. Prior to joining Schering-Plough in April 2003, Hassan was Chairman and Chief Executive Officer of Pharmacia Corporation-a company that was formed in March 2000 as a result of the merger of Monsanto and Pharmacia & Upjohn. Hassan joined Pharmacia & Upjohn as Chief Executive Officer in 1997. Previously, Hassan was Executive Vice President of Wyeth, formerly known as American Home Products, with responsibility for its pharmaceutical and medical products business. He was elected to Wyeth's Board of Directors in 1995. Earlier in his career, Hassan spent 17 years with Sandoz Pharmaceuticals (now Novartis) and headed its U.S. pharmaceuticals business.

Hassan received a B.S. degree in chemical engineering from the Imperial College of Science and Technology at the University of London and an MBA from Harvard Business School.